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Abstract 33 
Elongase of very long-chain fatty acids (Elovl) 4 probably plays a crucial role in 34 
marine fish species, where lack of Elovl2 has been considered as one possible reason 35 
for their low long-chain polyunsaturated fatty acids (LC-PUFAs) biosynthetic 36 
capability. Elovl4 is the most recent member of Elovl family that has been 37 
investigated in fish. Here we report the molecular cloning and functional 38 
characterization of putative elovl4 cDNA isolated from marine teleost Epinephelus 39 
coioides, and its expression in response to dietary n-3 LC-PUFA and docosahexaenoic 40 
acid (DHA) to eicosapentaenoic acid (EPA) ratio. The elovl4 cDNA of grouper was 41 
2341 bp including 301 bp of 5’-untranslated region (UTR), 918bp of the coding 42 
region that encodes a 305 amino acids (AA) and 1122bp of 3’UTR. Heterologous 43 
expression in yeast demonstrated that grouper Elovl4 could elongate saturated fatty 44 
acids (FA), especially 24:0 and 26:0, up to 36:0. Also, grouper Elovl4 effectively 45 
converted C20 and C22 polyunsaturated FAs to elongated polyenoic products up to 46 
C36. Tissue distribution analysis revealed that Elovl4 were widely transcribed in 47 
various tissues with the highest level in eye, brain and testis as described in other 48 
teleosts. The transcript level of elovl4 was significantly affected by dietary n-3 49 
LC-PUFA and high LC-PUFA level repress its expression. However, the ratio of DHA 50 
to EPA had no significant influence on its expression. These results may contribute to 51 
better understanding the LC-PUFA biosynthetic pathway in this fish species.  52 
 53 
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 56 
Introduction 57 
Long-chain polyunsaturated fatty acids (LC-PUFAs) (C≥20) are beneficial for 58 
human health, promoting the development of neuronal tissues and protect against 59 
cardiovascular, immune and inflammatory condition (Salem, Litman, Kim & 60 
Gawrisch 2001; Calon & Cole 2007; Eilander, Hundscheid, Osendarp, Transler & 61 
Zock 2007; Ruxton, Reed, Simpson & Millington 2004). Fish species, especially 62 
marine species, are the main source of LC-PUFAs for humans. However, with 63 
increasing use of vegetable oils in aqua feed, the contents of docosapentaenoic acid 64 
(DHA) and eicosapentaenoic acid (EPA) in farmed fish decreased significantly due to 65 
the lack of LC-PUFA in vegetable oils (Lin, Liu, He, Zheng & Tian 2007; Peng, Xu, 66 
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Mai, Zhou, Zhang, Liufu, Zhang & Ai 2014), which may severely impact its quality 67 
and value for human consumers. Therefore, the molecular mechanisms of the 68 
enzymes involved in the biosynthesis of LC-PUFAs in teleost are urgently better 69 
understood (Tocher 2003). 70 
The biosynthesis of LC-PUFAs in vertebrates is catalyzed by fatty acyl desaturase 71 
(Fads) and elongation of very long-chain fatty acids (Elovl) enzymes, which could 72 
convert the dietary essential α-linolenic acid (18:3n-3) and linoleic acid (18:2n-6) to 73 
LC-PUFAs, including the physiologically important DHA, EPA and arachidonic acid 74 
(ARA), through consecutive desaturation and elongation reactions (Sprecher 2000; 75 
Nakamura, Cho, Xu, Tang & Clarke 2001). Generally speaking, most marine fish, 76 
unlike freshwater species, have low LC-PUFA biosynthetic capacity due to lack or 77 
low specific enzyme activities involved in the pathway. Up to now, no Δ5 FAD cDNA 78 
has been isolated from any marine fish species other than a bifunctional Δ6/Δ5 FAD 79 
found in rabbitfish (Li, Monroig, Zhang, Wang, Zheng, Dick, You & Tocher 2010). 80 
Additionally, marine fish species also appear to lack Elovl2 which could elongate C20 81 
and C22 LC-PUFA and was regarded as an essential enzyme in DHA biosynthesis 82 
(Monroig, Rotllant, Sánchez, Cerdá-Reverter & Tocher 2009; Morais, Monroig, 83 
Zheng, Leaver & Tocher 2009). Elovl4 is the most recent member of Elovl family that 84 
has been investigated in fish (Monroig, Rotllant, Cerdá-Reverter, Dick, Figueras & 85 
Tocher 2010), although it has been proved to play a crucial rule in the biosynthesis of 86 
both saturated and polyunsaturated very long chain fatty acids (VLC-FAs) (C≥24) in 87 
mice (Cameron, Tong, Yang, Kaminoh, Kamiyah, Chen, Zeng, Chen, Luo & Zhang 88 
2007). Elovl4 cDNAs have been isolated and characterized in zebrafish (Monroig et al. 89 
2010), Atlantic salmon (Carmona-Antoñanzas, Monroig, Dick, Davie & Tocher 2011), 90 
cobia (Monroig, Webb, Ibarra-Castro, Holt & Tocher 2011) and rabbitfish (Monroig, 91 
Wang, Zhang, You, Tocher & Li 2012). Zebrafish possesses two Elovl4 enzymes, 92 
Elovl4a and Elovl4b. Both zebrafish Elovl4 proteins efficiently elongated saturated 93 
fatty acids up to C36. However, only Elovl4b could elongate PUFA substrates to 94 
corresponding elongated polyenoic products up to C36, with C20 PUFA appearing as 95 
preferred substrates (Monroig et al. 2010). As for marine fish species, the function of 96 
Elovl4 in rabbitfish and cobia were similar to Elovl4b. The ability of Elovl4 to 97 
effectively elongate C22 PUFA to C24 PUFA indicates that these enzymes have the 98 
potential to participate in the production of DHA, similar to Elovl2.  99 
During the past decades, a number of studies have been focused on the regulation 100 
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of those enzymes involved in LC-PUFA biosynthetic pathway. A few of them have 101 
been proved to be regulated by spatial temporal (Ishak, Tan, Khong, Jaya-Ram, Enyu, 102 
Kuah & Shu-Chien 2008; Tan, Chung & Shu-Chien 2010; Monroig et al. 2010), 103 
environmental factors (Zheng, Torstensen, Tocher, Dick, Henderson & Bell 2005) as 104 
well as nutrients (Zheng et al. 2005; Ling, Kuah, Sifzizul, Muhammad, Kolkovski & 105 
Shu-Chien 2006; Morais, Mourente, Ortega, Tocher & Tocher 2011). Studies on the 106 
regulation of those enzymes have been mainly focused on Fads2, Elovl5 and Elovl2. 107 
However, to our knowledge, little information was available on the regulation of 108 
elovl4. In the present study, the expression of elovl4 in response to dietary fatty acid 109 
was investigated. 110 
Orange-spotted grouper, Epinephelus coioides, is a popular fish cultured in 111 
Southeast Asia and good candidates for intensive aquaculture for their fast growth, 112 
efficient feed conversion and high market value (Millamena 2002). However, only 113 
few studies have been conducted to investigate the regulation of enzymes involved in 114 
LC-PUFA biosynthetic pathway of grouper. Only Li, Mai, Xu, Yuan, Zhang & Ai   115 
(2014) reported the expression of Δ6 FAD in response to dietary n-3 LC-PUFA. 116 
Therefore, it is crucial to understand the molecular mechanisms underlying the 117 
biosynthesis of PUFA in grouper, which could provide the basis for the successful 118 
substitution of fish oil and maintaining high levels of n-3 LC-PUFA in the flesh. 119 
Elovl4 plays a crucial role in early development of vertebrates (Monroig et al. 2010). 120 
In the present study, grouper larvae were chosen to investigate the effect of dietary 121 
fatty acid on expression of elovl4. The aim of the present study was conducted to 122 
clone the elovl4 cDNA, and investigate its characterization, tissue distribution and 123 
mRNA expression in response to dietary fatty acid.  124 
 125 
Materials and methods    126 
Experimental fish 127 
The grouper were bought from a local fish rearing farm in Yandun, Hainan, China. 128 
The body mass of grouper used for cloning, the rapid amplification of cDNA ends 129 
(RACE) and tissue distribution were 150.62±2.35g. The initial body weight of 130 
grouper larvae used for nutritional regulation study was 70±2mg (29 Day after hatch, 131 
DAH).  132 
 133 
6 
 
Cloning and sequencing of grouper Elovl4 cDNA  134 
Total RNA was isolated from grouper liver using Trizol Reagent (Takara, Tokyo, 135 
Japan) followed by quality measurement on a 1.2% denaturing agarose gel and yield 136 
determination on NanoDrop® ND-1000 (Wilmington, DE). The RNA was treated with 137 
RNA-Free DNase (Takara, Tokyo, Japan) to remove DNA contaminant and reversely 138 
transcribed to cDNA by PrimeScriptTMRT reagent Kit (Takara, Tokyo, Japan) 139 
according to the instructions provided by the manufacturer. 140 
First stand cDNA was synthesized using PrimeScriptTM RT reagent Kit (Takara, 141 
Tokyo, Japan) following the instructions. To obtain the first fragment of elovl4 cDNA 142 
of grouper, degenerate polymerase chain reaction (PCR) primers were designed based 143 
on highly conserved regions from elovl4 sequences of other fish (cobia, zebrafish and 144 
Atlantic salmon) in Genbank and were synthesized by Biosune Biotech (Shanghai, 145 
China). Two degenerate primers (Elovl4-F and Elovl4-R, Table 1) were designed to 146 
clone a fragment within the coding region by PCR. PCR program was carried out in 147 
Eppendorf Mastercycler Gradient (Eppendorf, Hamburg) and the PCR conditions 148 
were: 2min at 94°C; 35cycles of 30s at 94°C, 30s at 54°C, 40s at 72°C; another 10 149 
min at 72°C. The amplification products were separated by electrophoresis on a 1.5% 150 
agarose gel for length difference, and then the target band was ligated into the 151 
pEASY-T1 vector (TransGen Biotech, Beijing, China). The PCR fragment was 152 
sequenced in Biosune Biotech (Shanghai, China) and the nucleotide sequence was 153 
blasted on GenBank to confirm its high similarity with other Elovl4 proteins.  154 
The full-length cDNA sequence of elovl4 was obtained by 5’-and 3’-RACE using 155 
the SMARTer™ RACE cDNA Amplification Kit (Clontech, CA, USA). The 3’- and 156 
5’-ends cDNA templates were synthesized according to the user's manual. Four 157 
gene-specific primers, Elovl4-F1, Elovl4-F2, Elovl4-R1 and Elvol4-R2 were designed 158 
for the amplification of RACE cDNA fragments based on the obtained Elovl4 cDNA 159 
fragment (Table 1). For 3’ and 5’ RACE, gene-specific primers, Elovl4-F2 and 160 
Elovl4-R1, and Universal Primer A Mix (provided in the kit) was used in first round 161 
PCR. Then, nested PCR was performed with the other gene-specific primer, 162 
Elovl4-F1 and Elovl4-R2, for 3' and 5' RACE PCRs, respectively, and a nested 163 
universal primer (provided in the kit) to obtain specific PCR product. The PCR 164 
products were purified, cloned into, and sequenced as described above. 165 
 166 
Sequence and phylogenetic analysis of Elovl4  167 
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Sequence alignment and analysis were conducted using the BLAST sequence 168 
analysis service of National Center for Biotechnology Information 169 
(http://www.ncbi.nlm.nih.gov). Multiple alignments of elovl4 were performed with 170 
the ClustalW Multiple Alignment program (http://www.ebi.ac.uk/clustalw/). The 171 
deduced amino acid sequence of the newly cloned grouper elovl4 cDNAs was aligned 172 
with their corresponding orthologues from different species including human (Homo 173 
sapiens, NP_073563), mouse (Mus musculus, NP_683743), rat (Rattus norvegicus, 174 
NP_001178725), zebrafish (Danio rerio, NP_957090 and NP_956266), cobia 175 
(Rachycentron canadum, ADG59898), Atlantic salmon (Salmo salar, NP_001182481). 176 
Multiple sequence alignment was performed with Mega 4.0. A phylogenetic tree was 177 
constructed on the basis of amino acid sequence between the grouper Elovl cDNAs, 178 
vertebrate Elovl4, Elovl2 and Elovl5 proteins and using the neighbor joining method 179 
(Saitou & Nei 1987). Confidence in the resulting phylogenetic tree branch topology 180 
was measured by bootstrapping through 1000 iterations. 181 
 182 
Functional characterization of the grouper Elovl4 in yeast 183 
  The grouper Elovl4 function was determined by expressing its open reading frame 184 
(ORF) in Saccharomyces cerevisiae yeast cells as previously described (Monroig et al. 185 
2010; Carmona-Antoñanzas et al. 2011). Briefly, the ORF of the grouper elovl4 forms 186 
was amplified with primers containing restriction sites (Hind III and Ecor I) (Table 1) 187 
for further cloning into the yeast expression vector pYES2 (Invitrogen, Paisley, UK). 188 
The purified plasmids containing the putative elovl4 ORFs were then transformed into 189 
S. cerevisiae competent cells InvSc1 (Invitrogen) as previously described (Hastings, 190 
Agaba, Tocher, Leaver, Dick, Sargent & Teale 2001; Agaba, Tocher, Zheng, Dickson, 191 
Dick & Teale 2005). One single recombinant yeast colony was grown in S. cerevisiae 192 
minimal medium-uracil broth to produce a bulk culture required to run the functional 193 
assay as follows. In order to assess the role of the grouper Elovl4 in the biosynthesis of 194 
very long-chain (C>24) PUFA, individual flasks of transgenic yeast were 195 
supplemented with one of the following FA substrates: stearidonic acid (18:4n-3), 196 
-linolenic acid (18:3n-6), EPA (20:5n-3), arachidonic acid (20:4n-6), 197 
docosapentaenoic acid (22:5n-3), docosatetraenoic acid (22:4n-6) or DHA (22:6n-3). In 198 
order to test the ability of the grouper Elovl4 to elongate saturated VLC-FA, yeast 199 
transformed with pYES2 containing the putative elovl4 ORF or no insert 200 
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(pYES2-empty) (control) were incubated in triplicate in the absence of exogenously 201 
added substrates. The VLC-FA profiles from yeast transformed with pYES2-elovl4 and 202 
pYES2-empty were then compared. Docosapentaenoic and docosatetraenoic acids 203 
(>98-99 % pure) were purchased from Cayman Chemical Co. (Ann Arbor, USA) and 204 
the remaining FA substrates (>99 % pure) and chemicals used to prepare the S. 205 
cerevisiae minimal medium-uracil were from Sigma Chemical Co. Ltd. (Dorset, UK). 206 
After 2 days, yeast were harvested and washed for further analyses. Yeast transformed 207 
with pYES2 containing no insert were cultured under the same conditions as a control 208 
treatment. 209 
 210 
Fatty acid analysis of yeast 211 
Total lipids were extracted from yeast samples and used to prepare methyl esters 212 
(FAME) as described in detail previously by Monroig, Tocher, Hontoria & Navarro 213 
(2013). FAME were identified and quantified after splitless injection and run in 214 
temperature programming, in an Agilent 6850 Gas Chromatograph system, equipped 215 
with a Sapiens-5MS (30 m ×0.25µm×0.25µm) capillary column (Teknokroma, Sant 216 
Cugat del Vallés, Barcelona, Spain) coupled to a 5975 series MSD (Agilent 217 
Technologies, Santa Clara, CA, USA). The elongation of endogenous substrates was 218 
assessed by comparison of the areas of the FAs of control yeast with those of Elovl4 219 
transformed yeast. The elongation of exogenously added PUFA substrates (18:4n−3, 220 
18:3n−6, 18:4n−3, 20:5n−3, 20:4n−6, 22:5n−3 and 22:6n−3) was calculated by the 221 
stepwise proportion of substrate FA converted to elongated product as [areas of first 222 
product and longer chain products / (areas of all products with longer chain than 223 
substrate + substrate area)]×100.  224 
 225 
n-3 LC-PUFA levels and DHA/EPA study 226 
  For n-3 LC-PUFA level study, grouper larvae were obtained from tissue samples 227 
collected for a previous publication (Li et al. 2014). Briefly, Triplicate groups of 228 
grouper larvae (29DAH) were fed to apparent satiation six times daily for 4 weeks 229 
with five isoproteic (58% crude protein) and isolipidic (16% crude lipid) diets 230 
containing graded levels of n-3 LC-PUFA (0.52, 0.94, 1.57, 1.97 and 2.43%)( Table 231 
2&3).  232 
For DHA/EPA study, A total of 2100 larvae (29DAH, 70±2mg) were distributed 233 
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into 15 white plastic tanks (water volume 100L) at a stocking density of 140 234 
individuals per tank. Triplicate groups of grouper larvae were fed to apparent satiation 235 
six times daily for 4 weeks with five isoproteic (58% crude protein) and isolipidic 236 
(16% crude lipid) diets containing graded levels of DHA/EPA (0.82, 1.28, 1.67, 2.00 237 
and 2.33)(Table 4&5) and the total amount of n-3 LC-PUFA was approximately fixed 238 
at 2.0% of the dry weight. Five fish in each cage were pooled into 1.5 mL tube 239 
(RNase-Free, Axygen, USA), frozen in liquid nitrogen and then stored at -80°C for 240 
later analysis of Elovl4 expression. 241 
 242 
Real-time quantitative PCR (RT-qPCR) analysis  243 
The mRNA expression pattern of putative elovl4 in various tissues (eye, brain, 244 
testis, heart, liver, kidney, stomach, intestine and muscle) and samples from the larval 245 
rearing experiments were measured by RT-qPCR. β-actin (GenBank ID: AY510710) 246 
was selected as reference gene, and the stability of β-actin was verified and confirmed. 247 
Gene-specific primers for RT-qPCR of Elovl4 and β-actin (Table 1) were designed by 248 
Primer Primier 5.0 based on the cloned nucleotide sequences. 249 
The RT-qPCR was carried out in a quantitative thermal cycler 250 
(Mastercyclereprealplex, Eppendorf, Germany). The amplification was performed in a 251 
total volume of 25μL containing 2 × SYBR® Premix Ex Taq™ (Perfect Real Time) 252 
(Takara, Japan), 0.5μL of each primer (10μmol L-1), 1μL of cDNA mix. The program 253 
was as follows: 95°C for 2 min, followed by 40 cycles of 95°C for 10s, 57°C for 10s, 254 
and 72°C for 20s. At the end of each PCR reaction, melting curve analysis of 255 
amplification products was carried out to confirm that a single PCR product was 256 
present in these reactions. Standard curves were made with five different dilutions (in 257 
triplicate) of the cDNA samples and amplification efficiency was analyzed according 258 
to the following equation E=10(–1/Slope)-1. The primer amplication efficiency was 259 
0.9970 for elovl4, 1.008 for β-actin. The abosolute ∆CT value of the slope is 0.01, 260 
which indicated that ∆∆CT calculation for the relative quantification of target gene could 261 
be used. The expression levels of the target genes were calculated followed the 262 
2–ΔΔt method described by Livak & Schmittgen (2001). 263 
 264 
Statistical analysis 265 
The results were given as means ± S.E.M. (standard error of the mean). Data from 266 
each treatment were subjected to one-way ANOVA and correlation analysis where 267 
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appropriate using SPSS 19.0 for Windows. Tukey’s multiple range test was chosen as 268 
a multiple comparison test and the significance level of 5% was used. For the Elovl4 269 
functional characterization, the saturated VLC-FA profiles from yeast expressing the 270 
elovl4 were compared to those of control yeast transformed with the empty pYES2 271 
vector by a Student’s t-test (P<0.05). 272 
 273 
Result 274 
Sequence analyses of Grouper Elovl4  275 
Degenerate primers were used to amplify the PCR product of expected size (684bp) 276 
from grouper liver and the deduced amino acid sequence from the 684bp product was 277 
homologous to other known elovl4. Then, two end fragments were amplified by 278 
3’-RACE and 5’-RACE PCR based on the RACE technology. The complete cDNA 279 
sequence of elovl4 was obtained by assembling the three fragments (1st fragement 280 
and RACE products). The full-length sequence of elovl4 mRNA and the deduced 281 
amino acids (AA) are shown in Fig.1. The sequences corresponding to grouper 282 
elongase cDNAs (excluding the polyA tail) were 2341 bp. A 301 bp of 5’-untranslated 283 
region (UTR), 918bp of the coding region that encodes a 305 AA protein (Genbank ID: 284 
KF533722) and 1122bp of 3’UTR were included in the elovl4 cDNA sequence. The 285 
calculated molecular mass of the protein was estimated as 35.437 KDa by using 286 
Compute pI/Mw (http://web.expasy.org/compute_pi/). 287 
 288 
Multiple sequences alignment and phylogenetic analysis 289 
The analysis of deduced AA sequence of grouper elovl4 by BLAST indicated that 290 
elovl4 in orange-spotted grouper shares sequence identity with elovl4 of other teleosts, 291 
such as cobia (R. canadum, 94%), white-spotted rabbitfish (Siganus. canaliculatus, 292 
95%), Atlantic salmon (S. salar, 86%), zebrafish (D. rerio, 85%), more than 60% 293 
identity with elovl4 of human beings (H. sapiens, 65%), mouse (M. musculus, 65%) 294 
and cattle (B.Taurus, 65%). However, the deduced AA of grouper elovl4 was 40% 295 
identical with grouper elovl5 36-40% identical to teleost elovl5 sequences, 296 
respectively. 297 
The grouper elovl4 deduced proteins contained the diagnostic histidine box 298 
HXXHH motif conserved in all elongases and five membrane spanning domines. It 299 
also possessed a single lysine and arginine residues at the carboxyl terminus, RXKXX 300 
in elovl4 (Fig.2). The phylogenetic tree was constructed on basis of AA sequence 301 
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comparisons of grouper elovl4 and other elongase from fish (zebrafish, Atlantic 302 
salmon and rabbitfish) and human (Fig.3). The phylogenetic analysis showed that the 303 
grouper elovl4 clustered together with their corresponding teleost orthologues, and 304 
separately from elovl2 and elovl5 cluster. 305 
 306 
Functional characterization of grouper putative Elvol4 307 
The putative Elovl4 of grouper was functionally characterized by determining the 308 
fatty acid profiles of transformed S. cerevisiae with either empty pYES2 vector 309 
(control) or the vector containing elovl4 ORF inserts and grown in the presence of 310 
potential FA substrates. To test the ability of grouper to elongate saturated VLC-FA, 311 
transgenic yeast was grown incubated with lignoceric acid (24:0). Yeast transformed 312 
with the empty vector contained measurable amounts of saturated VLC-FA, 24:0, 26:0, 313 
28:0, 30:0 and 32:0 (Table 6). However, the elovl4-transformed yeast showed 314 
decreased amounts of 24:0 and 26:0, but increased amounts of 28:0, 30:0, 32:0 and 315 
34:0 (Table 6). These results confirmed that grouper Elovl4 is involved in the 316 
biosynthesis of saturated VLC-FA and at least 24:0, 26:0 and 28:0 may be the good 317 
substrates for grouper Elovl4. The role of grouper Elovl4 in the biosynthesis of 318 
VLC-PUFA was also investigated and transgenic yeast transformed with elovl4 ORF 319 
were incubated with C18 (18:4n-3 and 18:3n-6), C20 (20:5n-3 and 20:4n-6) and C22 320 
(22:5n-3, 22:4n-6 and 22:6n-3) PUFA substrates (Table 7; Fig.4). Fatty acid 321 
composition of the yeast transformed with only pYES2 shows four main fatty acid, 322 
namely 16:0, 16:1n-7; 18:0 and 18:1n-9, together with whichever exogenous FA 323 
added. However, GC–MS analyses confirmed that grouper Elovl4 could elongate 324 
PUFA to corresponding elongated polyenoic products up to C36 (Table 7; Fig.4). 325 
Elovl4 showed higher activity towards C20 (20:5n-3, 29.9% and 20:4n-6, 33.1%) and 326 
C22 (22:5n-3, 43.8% and 22:4n-6, 51.0%) and low activity towards C18 (18:4n-3, 327 
5.6% and 18:3n-6, 9.6%) (Table7). It’s noteworthy that grouper Elovl4 was able to 328 
convert both 20:5n-3 and 22:5n-3 to 24:5n-3, the substrate for DHA biosynthesis via 329 
the Sprecher shunt pathway (Sprecher 2000). However, grouper Elovl4 showed 330 
relative low activity towards DHA, consistent with the result in Suh & Clandinin 331 
(2005). 332 
 333 
Tissue expression of the putative elovl4 334 
The expression level of elovl4 varied among different tissues. The transcription of 335 
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elovl4 was detected in eye, brain, testis, heart, liver, kidney, stomach, intestine and 336 
muscle. Relatively high expression of elovl4 were observed in eye, brain and testis, 337 
then in liver and kidney, and weekly in heart, muscle, stomach and intestine. The 338 
highest transcriptional level of elovl4 was detected in eye and brain, more than 30 339 
folds than the corresponding value in muscle, stomach and intestine (Fig.5). 340 
 341 
Effect of n-3LC-PUFA levels and DHA/EPA on the expression of the putative elovl4 342 
  Relative mRNA expression of elovl4 of grouper larvae was significantly affected by 343 
dietary n-3 LC-PUFA (P<0.05). The relative expression of elovl4 in the first two 344 
treatments was significant higher than 2.43% n-3 LC-PUFA group. The elovl4 345 
transcript levels were up-regulated by 0.41-fold, 0.79-fold, 0.31-fold and 0.26-fold in 346 
the level of 0.52%, 0.94%, 1.57% and 1.97% treatments compared with the treatment 347 
of 2.43% n-3 LC-PUFA, respectively (Fig.6a). The mRNA level of elovl4 also showed 348 
significantly negative linear relationship relative to dietary n-3 LC-PUFA with an 349 
R=0.7467 (Y= -0.1351X +1.352). However, no significant differences were observed 350 
in the expression of Elovl4 in larvae fed diets with graded levels of DHA/EPA 351 
(Fig.6b).    352 
 353 
Discussion 354 
Elovl are crucial enzymes for the condensation of activated fatty acids with 355 
malonyl-CoA in the long-chain fatty acid elongation pathway (Nugteren 1965). Fish 356 
Elovl cDNAs including elovl5 and elovl2 have been cloned and functionally 357 
characterized from several species including freshwater species, the salmonids and 358 
marine species (Agaba, Tocher, Dickson, Dick & Teale  2004; Agaba et al. 2005; 359 
Meyer, Kirsch, Domergue, Abbadi, Sperling, Bauer, Cirpus, Zank, Moreau & Heinz 360 
2004; Hastings, Agaba, Tocher, Zheng, Dickson, Dick & Teale 2004; Zheng, Ding, Xu, 361 
Monroig, Morais & Tocher 2009; Mohd-Yusof, Monroig, Mohd-Adnan, Wan & 362 
Tocher 2010; Morais et al. 2009; Monroig et al. 2012; Gregory, See, Gibson & 363 
Schuller 2010). In recent years, Elovl4 has been discovered in zebrafish (Monroig et 364 
al. 2010), Atlantic salmon (Carmona-Antoñanzas et al. 2011), cobia (Monroig et al. 365 
2011) and rabbitfish (Monroig et al. 2012). Through the functional characterization in 366 
heterologous expression in S. cerevisiae, the ability of Elovl4 to effectively elongate 367 
C22 PUFA made it possible to form DHA from EPA.  368 
In the present study, a full-length cDNA of a putative elovl4 was first cloned in 369 
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orange-spotted grouper. The deduced 305 AA showed high identity with elovl4 of 370 
other teleosts, particular cobia (R. canadum, 94%), white-spotted rabbitfish (S. 371 
canaliculatus, 95%), Atlantic salmon (S. salar, 86%), zebrafish (D. rerio, 85%). The 372 
putative grouper elovl4 deduced proteins possessed conserved region, the diagnostic 373 
histidine box HXXHH motif, conserved in all elongases and also characteristic of 374 
desaturase and hydrolase enzymes containing a di-iron-oxo cluster (Fe-O-Fe), which 375 
was involved in the coordination of electron reception during reactions occurring 376 
during FA elongation (Jakobsson, Westerberg & Jacobsson 2006). The putative 377 
grouper elovl4 possessed an arginine residue and one lysine residue (RXKXX) in 378 
position -5 and -3 from the C-terminus of the protein, respectively, which was crucial 379 
for endoplasmatic reticulum retrieval signal function (Jackson, Nilsson & Peterson 380 
1990). The RXKXX pattern, indicating its role in LC-PUFA synthesis (Cook & 381 
McMaster 2004), is common to other teleost elovl4 including cobia, white-spotted 382 
rabbitfish, Atlantic salmon and zebrafish elovl4a (Monroig et al. 2010, 2011, 2012; 383 
Carmona-Antoñanzas et al. 2011).   384 
The phylogenetic analysis revealed that the grouper elovl4 cDNA encodes a 385 
protein more similar to the other Elovl4 orthologues from teleosts and mammals, than 386 
other Elovl family in fish species, the Elovl2 and Elovl5. Zebrafish have two Elovl4, 387 
Elovl4a and Elovl4b, and they showed marked differences in their substrate 388 
specificity (Monroig et al. 2011). Elovl4a could only efficiently elongated saturated 389 
VLC-FA up to C36, whilst Elovl4b could elongate PUFA substrates to corresponding 390 
elongated polyenoic products (Monroig et al. 2010). The teleost Elovl4 proteins were 391 
separated to two groups, with zebrafish Elovl4a separated with Zebrafish Elovl4b and 392 
other teleost Elovl4. Previous studies have found that the function of Elovl4 in cobia, 393 
white-spotted rabbitfish and Atlantic salmon was similar to Elovl4b in zebrafish 394 
(Monroig et al. 2011, 2012; Carmona-Antoñanzas et al. 2011). Compared with 395 
Elovl4a, the phylogenetic analysis indicate that the grouper Elovl4 has close kinship 396 
to Elovl4b, which may indicate that the function of grouper Elovl4 was similar to 397 
Elovl4b.  398 
The functional characterization of grouper Elovl4 was also investigated in the 399 
present study and it was convinced that the function of grouper Elovl4 was great 400 
similarities to zebrafish Elovl4b. Briefly, grouper Elovl4 was efficient in the 401 
biosynthesis of saturated VLC-FA, with 24:0, 26:0 and 28:0 as preferred substrates. 402 
Meanwhile, grouper Elovl4 also showed high efficiency in the elongation of C20 403 
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(20:5n-3 and 20:4n-6) and C22 (22:5n-3 and 22:4n-6) PUFA to corresponding 404 
elongated polyenoic products with C36 chain-lengths. It has been reported that 405 
VLC-FAs were abundant in retina (Aveldaño 1987) and brain (Robinson, Johnson & 406 
Poulos 1990) and testis (Zadravec, Tvrdik, Guillou, Haslam, Kobayashi, Napier, 407 
Capecchi & Jacobsson 2011), in which was consistent with the tissue distribution 408 
analysis of elovl4 mRNA transcripts. This may indicate that brain, eye and testis were 409 
the prominent metabolic sites for the biosynthesis of VLC-FA. Unlike freshwater 410 
species and the salmonids, marine fish species also appear to lack Elovl2, regarded as 411 
an essential enzyme in DHA biosynthesis (Monroig et al. 2009; Morais et al. 2009). 412 
However, along with the discovery of Elovl4, marine fish species could also 413 
synthesize DHA from EPA through sprecher pathway (Monroig et al. 2011). It was 414 
found in the present study that grouper Elovl4 have higher activity towards C20 415 
(20:5n-3 and 20:4n-6) and C22 (22:5n-3 and 22:4n-6). In particular, grouper Elovl4 416 
was able to effectively convert both 20:5n-3 and 22:5n-3 to 24:5n-3, the substrate for 417 
DHA biosynthesis via the Sprecher shunt pathway (Sprecher 2000). This may indicate 418 
the potential role of grouper Elovl4 in the biosynthesis of DHA and Elovl4 could 419 
compensate for the lacking of Elovl2 in marine fish species. 420 
The content of DHA and EPA, potentially compromising their nutritional benefit to 421 
the human consumer, was reduced with the increasing use of vegetable oils, which are 422 
devoid of LC-PUFA (Izquierdo, Obach, Arantzamendi, Montero, Robaina & 423 
Rosenlund 2003; Torstensen, Frøyland, Ørnsrud & Lie 2004). The research on 424 
regulational mechanism of the enzymes involved in LC-PUFA biosynthesic pathway 425 
may make effective use of vegetable oil in aquafeeds (Tocher 2010). However, studies 426 
of those enzymes of teleosts involved in LC-PUFA biosynthetic pathway remain in 427 
transcriptional level, and mainly focused on Fads2, Elovl5 and Elovl2. As for Elovl4, 428 
Monroig et al. (2010) have studied spatial-temporal expression of zebrafish elovl4 429 
genes. However, to the best of our knowledge, little information was available on 430 
nutritional regulation of elovl4. In the present study, the mRNA expression of elovl4 431 
was downregulated by dietary n-3 LC-PUFA. Meanwhile, similar results have been 432 
found in the study of elovl5 expression (Zheng et al. 2005; Ling et al. 2006; Morais et 433 
al. 2011). This may indicate that the nutritional regulation of elovl4 may have some 434 
characteristics similar to elovl5. The same changing trend of elovl4 and elovl5 435 
expression in response to dietary n-3 LC-PUFA may confirm the hypothesis to some 436 
extent. Unlike the response to dietary n-3 LC-PUFA, the expression of elovl4 was not 437 
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significantly affected by the level of DHA/EPA in the present study. In the study of 438 
salmon, it was found that both DHA and EPA have similar effects on regulating the 439 
expression of LXR and SREBP-1, potential regulator of fatty acid desaturase and 440 
elongation ((Minghetti, Leaver & Tocher 2011). Although Elovl4 has the ability to 441 
elongate EPA to form DHA, the similar effect on transcription factor (LXR and 442 
SREBP-1) may account for the response of elovl4 to dietary DHA/EPA and further 443 
study should be conducted to investigate the specific regulation mechanism.  444 
In conclusion, the cDNA of elovl4 was first cloned from orange-spotted grouper. 445 
The elovl4 possessed all the features of Elovl proteins and is phylogenetically close to 446 
other elovl4 orthologues of teleosts. Heterologous expression in yeast demonstrated 447 
that grouper Elovl4 could elongate saturated fatty acids (FA), especially 24:0 and 26:0, 448 
up to 36:0. Also, grouper Elovl4 effectively converted C20 and C22 polyunsaturated 449 
FAs to elongated polyenoic products up to C36. High LC-PUFA level significant 450 
decreased the expression of elovl4, while the level of DHA/EPA have no significant 451 
influence on it.  452 
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Figure legends 646 
Fig. 1. Nucleotide and deduced amino acid sequences of Elovl4 gene. Uppercase 647 
letters indicate the translated region and lowercase letters indicate the untranslated 648 
region. The start codon (ATG) and the stop codon (TAG) are in bold. 649 
Double-underlined letters indicate the polyadenylation signal (AATAA).  650 
Fig.2. Comparison of the deduced amino acid sequences of Elovl4 from orange 651 
spotted grouper, other fish, mouse and human. The AA sequences were aligned using 652 
ClustalX, and identity/similarity shading was based on a 75% identity threshold. 653 
Identical residues are shaded black and similar residues are shaded grey. Indicated are 654 
the conserved HXXHH histidine box motif, five (I–V) putative membrane-spanning 655 
domains and the ER retrieval signal predicted by Zhang, Yang, Karan, Hashimoto, 656 
Baehr, Yang & Zhang (2003). 657 
Fig.3. Phylogenetic tree comparing the grouper Elovl4 with elongase proteins from 658 
other organisms. The tree was constructed using the Neighbor Joining method (Saitou 659 
and Nei, 1987) using MEGA4. The horizontal branch length is proportional to amino 660 
acid substitution rate per site. The numbers represent the frequencies (%) with which 661 
the tree topology presented was replicated after 1000 iterations. 662 
Fig.4. Role of grouper Elovl4 in the biosynthesis of very long-chain fatty 663 
acids(VLC-PUFA). Yeast transformed with pYES2 vector containing the elovl4 ORF 664 
was grown in the presence of PUFA substrates 20:5n-3 (A) and 22:5n-3 (B), and fatty 665 
acid composition was determined. Substrates (“*”) and their corresponding elongated 666 
products are indicated accordingly. Vertical axis, MS response; horizontal axis, 667 
retention time.  668 
Fig.5. Tissue expression of Elovl4 in orange-spotted grouper. Results are expressed as 669 
mean±standard error (n=3). Different letters above the bars denote significant (P<0.05) 670 
differences among tissues.  671 
Fig.6. Relative mRNA expression of elovl4 in visceral mass of grouper fed diets with 672 
graded levels of n-3 LC-PUFA (a) and DHA/EPA (b). Results are expressed as 673 
means±standard error (n=3). Different letters above the bars denote significant 674 
(P<0.05) differences among dietary groups. A line with R value was shown across the 675 
five bars if significant linear relationship was detected (P<0.05). 676 
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1        ACATGGGGGATGATGCGGCTGAGCGGCCGGCACGGACTGAATGCATAATTGGCCTATCTTAGTCATAGATTTTAACTTGCCTTGTCTAGT 
91       TTCTTGCCAAATTGCTGTTTAATGTGGAACTGTAGCCGGAGCGGCGTAGAAACTGAGTAGCAGTAACGGCAGCAGAAGAAGAAGAAGAAG 
181       GAGACGAAGAACAAGAAGAGGAGCGCAGCCGTAACTGAGAGGAGTTGGGCATCAAATTGCACCGGATGTCATTACACGCTTTTAAATATC 
271       GAGGACTATAATCAGGACCAAAGGCAGAGCCATGGAGGTTGTAACACATCTTGTGAATGACACTGTAGAATTTTACAAATGGGGCCTTAC 
1                                        M  E  V  V  T  H  L  V  N  D  T  V  E  F  Y  K  W  G  L  T  
361       TATAGCAGACAAGAGGGTGGAGAACTGGCCAATGATGTCATCTCCAGTCCCCACTCTGGCCATCAGCTGCCTGTACCTGTTCTTCCTGTG 
21         I  A  D  K  R  V  E  N  W  P  M  M  S  S  P  V  P  T  L  A  I  S  C  L  Y  L  F  F  L  W  
451       GGCAGGGCCTAGATACATGCAGGACCGCCAGCCCTATACACTCAGGAAGACCCTCATAGTCTACAACTTCAGCATGGTGGTTCTCAACTT 
51         A  G  P  R  Y  M  Q  D  R  Q  P  Y  T  L  R  K  T  L  I  V  Y  N  F  S  M  V  V  L  N  F  
541       CTACATCGCCAAAGAGCTCCTACTAGGCTCTAGAGCAGCCGGGTACAGCTACCTCTGTCAGCCTGTCAACTACTCCAATGATGTCAACGA 
81         Y  I  A  K  E  L  L  L  G  S  R  A  A  G  Y  S  Y  L  C  Q  P  V  N  Y  S  N  D  V  N  E  
631       AGTCAGGATAGCATCTGCTCTCTGGTGGTACTACATCTCCAAAGGAGTGGAATTCTTGGACACAGTGTTTTTCATCCTGAGGAAGAAGTT 
111         V  R  I  A  S  A  L  W  W  Y  Y  I  S  K  G  V  E  F  L  D  T  V  F  F  I  L  R  K  K  F  
721       CAACCAGGTCAGCTTCCTCCACGTCTACCATCACTGCACCATGTTCATTCTCTGGTGGATCGGCATCAAATGGGTCCCCGGTGGACAGTC 
141         N  Q  V  S  F  L  H  V  Y  H  H  C  T  M  F  I  L  W  W  I  G  I  K  W  V  P  G  G  Q  S  
811       ATTTTTTGGTGCAACCATCAACTCTTCCATCCATGTCCTCATGTACGGTTACTACGGCCTGGCAGCTCTGGGACCTCAGATGCAGAAGTA 
171         F  F  G  A  T  I  N  S  S  I  H  V  L  M  Y  G  Y  Y  G  L  A  A  L  G  P  Q  M  Q  K  Y  
901       CCTCTGGTGGAAGAAATACCTCACCATTATTCAGATGATCCAGTTCCACGTGACCATCGGCCACGCCGGCCACTCCCTCTACACAGGCTG 
201         L  W  W  K  K  Y  L  T  I  I  Q  M  I  Q  F  H  V  T  I  G  H  A  G  H  S  L  Y  T  G  C  
991       TCCGTTCCCCGCCTGGATGCAGTGGGCTCTGATTGGCTACGCCGTCACTTTCATCATCCTCTTCGCCAACTTCTACTACCACGCTTACCG 
231         P  F  P  A  W  M  Q  W  A  L  I  G  Y  A  V  T  F  I  I  L  F  A  N  F  Y  Y  H  A  Y  R  
1081      ACGCAAACCCTCTTCCACGCATAAGGGAGGCAAGCCCGTCGCAAACGGCACATCTACGGTAACTAACGGTCATAGCAAAGTGGAGGAGGT 
261         R  K  P  S  S  T  H  K  G  G  K  P  V  A  N  G  T  S  T  V  T  N  G  H  S  K  V  E  E  V  
1171      GGAGGATAACGGGAAGAGGCAGAAGAAAGGACGAGCGAAAAGGGAGTAAAGAAGGAAGAGGGGCCCGCGTGGCGATTAAAGGAAAGAGGA 
291         E  D  N  G  K  R  Q  K  K  G  R  A  K  R  E  *   
1261      CAGTTGTTTTAAGGGCCAGAGAAGCAGGGAGGGTAGGGAAGGGATAAACAGAAACCAGACCGGCTTCATCATCCCTGCAAATAACGTAGA 
1351      CGGATGTGATTTGTGACCAACTCGGGAAGGTGAAAGGGTAGAAGTGTGTGTGTTGTGTCTGTACGGGGGTTTGAGAGGAAGAGAGGGGTG 
1441      TTGGTTGTCTCCATTACAGTTTTTTTTTTTAAATATCAAGAAAAGCAAGATACTGATCACGTAGGCTCCGCGCTCTGCTGTCCAACTGTG 
1531      TTTTGGACCGTAACAGGACCAAAATATTAAAGGACCTACACACTGCTCAGCATCCTCTAACTTATCAACCAAAATTCACCTCCAACTTTT 
1621      GTACTCTGGATTCCAGTATTGTTTTAACTGAAAGCTTAAATAGTCTTTAATATGCTAATTTATTTTATAGTGCTCTGAAAGAGTTTTAAT 
1711      GACTTTAACTATTACCAACAAAACACATGCAGATGTTTATACCAAAGGTTTTCGGGGGGCTAATTATTTTTGTTTACGAACACTTAGAGC 
1801      AAAGATAGGGAACGGAAAAATCCCAATACGATGTTTTCACAACTGCCATCAACCAATCATCGACCAATCCAACATGTCATGGACTTTTTT 
1891      TGCTGTTTGATAAACTGATATAACTGTGCTGCATTTACAGATGATTATTTTTTTCGTGTTCATTGTGAATTAAAAACCTGGTTTAAAACA 
1981      CTTTGGGGGAGGGCGACTGTAGTTTCTTTTAGTATTTATGCAAATTTGTGGGTATCTTTGTTAATAATATTTTTTTTTTGTGTGTCCTCA 
2071      CGATTTATTCCTTTTTTGCTGTGTGACGTAGCCGAGGTGCAAGAATAAGAAATTTGAAATTCAGCTCAATATTGTCTCACTGCCATGTAG 
2161      GACTGAAGGGAAACTCCTCCTGACAAGAGCTTTTTTTTTTTTTCTTTTTTTTTTTGTAAAGAAAACAAACGGCTATTTCATTGTCTTAAT 
2251      AAGAAAGCGGACACAGCTTCTGGCTGCACATATAACTGAAATAAAGACAATGTCACCCCCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAA 
2252      A 
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Fig.2 
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Fig.3. 
 
 Siganus canaliculatus Elovl4 (JF320823)
 Epinephelus coioides Elovl4 (KF533722)
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 D. rerio Elovl4b (NM_199972)
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 Danio rerio Elovl4a (NM_200796)
 gallus gallus Elovl4 (XM_419868)
 Bos Taurus Elovl4 (NM_001099050)
 Ovis aries Elovl4 (XM_004011121)
 Homo sapiens Elovl4 (NM_022726)
 Mus musculus Elovl4 (NM_148941)
 Rattus norvegicus Elovl4 (XM_001062735)
 D. rerio Elovl2 (NM_001040362)
 S. salar Elovl2 (FJ237523)
 M. musculus Elovl2 (NM_019423)
 H. sapiens Elovl2 (NM_017770)
 D. rerio Elovl5 (NM_200453)
 S. salar Elovl5 (FJ237531)
 R. canadum Elovl5 (FJ440239)
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Fig.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
 
Fig.6a 
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Tables 
Table 1. Sequences of the PCR primers used in this work. 
Primer Sequences (5’-3’) Purpose 
Elovl4-F AGACAAGMGKGTGGAGAAATG RT primer 
Elovl4-R AGGATGATGAARGTGACRGCG RT primer 
Elovl4-F1 CTTCCTGAGTGTATAGGGCTGGCGGTC 5’RACE primer 
Elovl4-F2 GCATCTGAGGTCCCAGAGCTGCCAG 5’RACE primer 
Elovl4-R1 GCAGGACCGCCAGCCCTATACACTCAG 3’RACE primer 
Elovl4-R2 GGCTCTGATTGGCTACGCCGTCACCTT 3’RACE primer 
gE4-HindIII-F CCCAAGCTTATGGAGGTTGTAACACATCT Functional characterization 
gE4-EcorI-R1 CCGCTCGAGTTACTCCCTTTTCGCTCGTC Functional characterization 
UPM Long: CTAATACGACTCACTATAG GGCAAGCAGTGGTATCAACGC AGAGT RACE method 
 
Short: CTAATACGACTCACTATAGGGC RACE method 
NUP AAGCAGTGGTATCAACGCAGAGT RACE method 
Elovl4-qF CTTTCATCATCCTCTTCGCC RT-qPCR 
Elovl4-qR TTACTCCCTTTTCGCTCGTC RT-qPCR 
βactin-F TACGAGCTGCCTGACGGACA RT-qPCR 
βactin-R GGCTGTGATCTCCTTCTGCA RT-qPCR 
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Table 2: Formulation and proximate analysis of the experimental diets with graded 
levels of n-3 LC-PUFA (% dry weight). 
Ingredients (%) Dietary n-3 LC-PUFA contents (% dry weight) 
  0.52 0.94 1.57 1.97 2.43 
Caseina 13 13 13 13 13 
Defatted white fish meala 35 35 35 35 35 
Defatted krill meala 10 10 10 10 10 
Squid meala 5 5 5 5 5 
Hydrolyzed fish meala 8 8 8 8 8 
LT-Yeasta 2 2 2 2 2 
Alginate sodium 2 2 2 2 2 
α-starch 5 5 5 5 5 
Vitamin premixb 1.5 1.5 1.5 1.5 1.5 
Mineral premixc 1.5 1.5 1.5 1.5 1.5 
Attractantd 1.5 1.5 1.5 1.5 1.5 
Ethoxyquin 0.1 0.1 0.1 0.1 0.1 
Choline chloride 0.2 0.2 0.2 0.2 0.2 
DHA enriched oile 0.33 1.45 2.56 3.66 4.8 
EPA enriched oilf 0.02 0.66 1.31 1.95 2.58 
Palmiting 9.75 7.99 6.23 4.49 2.72 
ARA enrich oilh 1 1 1 1 1 
Soy lecithin 4 4 4 4 4 
Mold inhibitori 0.1 0.1 0.1 0.1 0.1 
Proximate analysis (n=3)      
Crude protein (%) 57.98 57.21 57.15 57.20 57.71 
Crude lipid (%) 15.09 15.24 15.11 15.46 15.75 
Ash (%) 16.08 16.11 15.29 15.30 15.19 
a Casein: crude protein 87.91% dry matter, crude lipid 1.69% dry matter; Defatted fish 
meal: crude protein 73.36% dry matter, crude lipid 1.52% dry matter; Defatted Krill 
meal: crude protein 71.80% dry matter, crude lipid 2.93% dry matter; Squid meal: 
crude protein 61.72% dry matter, crude lipid 3.16% dry matter; Hydrolyzed fish 
meal: crude protein 77.10% dry matter, crude lipid 4.60% dry matter. 
bVitamin premix(IU or g kg–1 vitamin premix): retinal palmitate, 3,000,000 IU; 
cholecalciferol, 1,200,000 IU; DL–α–tocopherol acetate, 40.0 g; menadione, 8.0 g; 
thiamin–HCl, 5.0g; riboflavin, 5.0 g; D–calcium pantothenate, 16.0 g; 
pyridoxine–HCl, 4.0 g; meso–inositol, 200.0 g; D–biotin, 8.0 g; folic acid, 1.5 g; 
para–aminobenzoic acid, 5.0 g; niacin, 20.0 g; cyanocobalamin, 0.01 g; ascorbyl 
polyphosphate (contained 25% ascorbic acid), 100.0 g. 
cMineral premix（g kg–1）：Ca(H2PO4)2·H2O, 675.0; CoSO4·4H2O, 0.15; CuSO4·5H2O, 
5.0；FeSO4·7H2O, 50.0; KCl, 50.0; KI, 0.1; MgSO4.2H2O, 101.7；MnSO4·4H2O, 18.0; 
NaCl, 80.0; Na2SeO3·H2O, 0.05; ZnSO4·7H2O, 20.0. 
dAttractant(g 100g-1): betaine, 50; glycine,15; alanine, 10;argine,10; taurine, 10; 
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inosine-5’-monophosphoric acid, 5. 
eDHA enriched oil: DHA content, 40.64% of TFA; in the form of DHA-methylester; 
JIANGSU TIANKAI Biotechnology Co., Ltd., China. 
fEPA enriched oil: EPA content, 46.41% of TFA; DHA content, 23.66% of TFA; both 
in the form of triglyceride; HEBEI HAIYUAN Health biological Science and 
Technology Co., Ltd., China. 
gPalmitin: Palmitic acid content, 98.7% of TFA, in the form of methylester; Shanghai 
Zhixin Chemical Co., Ltd., China. 
hARA enriched oil: ARA content, 53.69% of TFA, in the form ofof ARA-methylester; 
JIANGSU TIANKAI Biotechnology Co., Ltd., China. 
iMold inhibitor: contained 50% calcium propionic acid and 50% fumaric acid. 
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Table 3: Fatty acid composition of the experimental diets with graded levels of n-3 
LC-PUFA (% total fatty acids) 
aSFA: saturated fatty acids. 
bMUFA: mono-unsaturated fatty acids. 
cn-6 PUFA: n-6 poly-unsaturated fatty acids. 
d n-3 PUFA: n-3 poly-unsaturated fatty acids. 
en-3 LC-PUFA: n-3 long chain polyunsaturated fatty acids. 
fDHA/EPA: 22:6n-3/20:5n-3. 
gEPA/ARA: 20:5n-3/20:4n-6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fatty acid Dietary n-3 LC-PUFA contents (% dry weight) 
  0.52 0.94 1.57 1.97 2.43 
14:0 1.17  1.51  2.08  2.35  2.72  
16:0 69.64  59.20  47.90  44.71  34.05  
18:0 1.50  1.81  1.98  1.91  2.10  
20:0 0.73  0.85  1.05  1.09  1.21  
∑SFAa 73.04  63.37  53.01  50.06  40.08  
18:1 6.23  6.47  6.87  6.63  6.96  
∑MUFAb 6.23  6.47  6.87  6.63  6.96  
18:2n-6 8.36  8.95  10.76  9.00  9.25  
18:3n-6 0.38 0.27 0.45 0.34 0.40 
20:4n-6 2.81  3.20  3.48  3.41  3.77  
∑n-6PUFAc 11.55 12.42 14.69 12.75 13.42  
18:3n-3 1.01  1.08  1.41  1.02  1.06  
18:4n-3 0.29 0.32 0.44 0.37 0.43 
20:5n-3 1.48  3.11  5.34  6.71  8.56  
22:6n-3 2.92  6.09  11.04  13.78  18.22  
∑n-3PUFAd 5.70 10.59 18.23 21.88 28.27 
n-3/n-6PUFA 0.48  0.85  1.25  1.73  2.14  
n-3LC-PUFAe 4.40  9.20  16.38  20.49  26.78  
DHA/EPAf 1.98  1.96  2.07  2.05  2.13  
EPA/ARAg 0.53 0.97 1.53 1.97 2.27 
32 
 
Table 4: Formulation and proximate analysis of the experimental diets with graded 
levels of DHA/EPA (% dry weight). 
Ingredients DHA/EPA ratio 
  0.82 1.28 1.67 2.01 2.33 
White fish meala 49.00 49.00 49.00 49.00 49.00 
Krill meala 15.00 15.00 15.00 15.00 15.00 
Squid meala 4.00 4.00 4.00 4.00 4.00 
Hydrolyzed fish meala 8.00 8.00 8.00 8.00 8.00 
LT-Yeast 2.00 2.00 2.00 2.00 2.00 
α-starch 4.50 4.50 4.50 4.50 4.50 
Alginate sodium 2.00 2.00 2.00 2.00 2.00 
Vitamin premixb 1.50 1.50 1.50 1.50 1.50 
Mineral premixc 1.50 1.50 1.50 1.50 1.50 
Attractantd 1.50 1.50 1.50 1.50 1.50 
Antioxidant 0.10 0.10 0.10 0.10 0.10 
Choline chloride 0.20 0.20 0.20 0.20 0.20 
DHA enriched oile 0.55 1.92 2.82 3.45 3.89 
EPA enriched oilf 2.35 1.51 0.98 0.60 0.33 
Palmiting 2.70 2.17 1.80 1.55 1.38 
ARA enrich oilh 1.00 1.00 1.00 1.00 1.00 
Soy lecithin 4.00 4.00 4.00 4.00 4.00 
Mold inhibitori 0.10 0.10 0.10 0.10 0.10 
Proximate analysis (n=3)      
Crude protein (%) 56.11 55.77 55.56 55.32 55.94 
Crude lipid (%) 17.36 17.56 17.10 18.37 17.80 
Ash (%) 16.86 16.71 17.42 16.82 17.13 
DHA/EPA 0.82 1.28 1.67 2.01 2.33 
n-3HUFA 2.02 2.01 2.02 2.02 2.02 
a White fish meal: crude protein 71.18% dry matter, crude lipid 5.32% dry matter; 
Krill meal: crude protein 63.76% dry matter, crude lipid 12.95% dry matter; Squid 
meal: crude protein 61.72% dry matter, crude lipid 3.16% dry matter; Hydrolyzed 
fish meal: crude protein 77.10% dry matter, crude lipid 4.60% dry matter. 
bVitamin premix(IU or g kg–1 vitamin premix): retinal palmitate, 3,000,000 IU; 
cholecalciferol, 1,200,000 IU; DL–α–tocopherol acetate, 40.0 g; menadione, 8.0 g; 
thiamin–HCl, 5.0 g; riboflavin, 5.0 g; D–calcium pantothenate, 16.0 g; 
pyridoxine–HCl, 4.0 g; meso–inositol, 200.0 g; D–biotin, 8.0 g; folic acid, 1.5 g; 
para–aminobenzoic acid, 5.0 g; niacin, 20.0 g; cyanocobalamin, 0.01 g; ascorbyl 
polyphosphate (contained 25% ascorbic acid), 100.0 g. 
cMineral premix（g kg–1）：Ca(H2PO4)2·H2O, 675.0; CoSO4·4H2O, 0.15; CuSO4·5H2O, 
5.0；FeSO4·7H2O, 50.0; KCl, 50.0; KI, 0.1; MgSO4.2H2O, 101.7；MnSO4·4H2O, 18.0; 
NaCl, 80.0; Na2SeO3·H2O, 0.05; ZnSO4·7H2O, 20.0. 
dAttractant(g 100g-1): betaine, 50; glycine, 15; alanine, 10; argine, 10; taurine, 10; 
inosine-5’-monophosphoric acid, 5. 
eDHA enriched oil: DHA content, 40.64% of TFA; in the form of DHA-methylester; 
JIANGSU TIANKAI Biotechnology Co., Ltd., China. 
 fEPA enriched oil: EPA content, 46.41% of TFA; DHA content, 23.66% of TFA; both 
in the form of triglyceride; HEBEI HAIYUAN Health biological Science and 
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Technology Co., Ltd., China. 
gPalmitin: Palmitic acid content, 98.7% of TFA, in the form of methylester; Shanghai 
Zhixin Chemical Co., Ltd., China. 
hARA enriched oil: ARA content, 53.69% of TFA, in the form of of ARA-methylester; 
JIANGSU TIANKAI Biotechnology Co., Ltd., China. 
iMold inhibitor: contained 50% calcium propionic acid and 50% fumaric acid. 
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Table 5: Fatty acid composition of the experimental diets with graded levels of 
DHA/EPA (% total fatty acids) 
Fatty acid Dietary DHA/EPA  
  0.82 1.28 1.67 2.01 2.33 
14:0 3.08  3.53  3.93  4.09  4.13  
16:0 28.91  29.06  27.34  27.02  26.07  
18:0 2.06  2.08  2.08  2.06  2.01  
20:0 2.95  2.72  2.63  2.64  2.72  
∑SFAa 36.99  37.39  35.98  35.82  34.93  
16:1 3.74  3.89  3.81  3.96  3.69  
18:1 12.32  12.30  12.16  12.18  11.75  
∑MUFAb 16.06  16.19  15.97  16.14  15.43  
18:2n-6 8.84  8.82  9.01  8.93  8.62  
20:4n-6 3.81  3.17  3.62  3.45  3.39  
∑n-6PUFAc 12.66  11.99  12.63  12.38  12.01  
18:3n-3 1.24  1.14  1.13  1.10  1.11  
20:5n-3 12.82  10.14  8.59  7.60  6.66  
22:6n-3 10.52  12.96  14.35  15.26  15.50  
∑n-3PUFAd 24.57  24.24  24.07  23.96  23.28  
n-3/n-6PUFA 1.94  2.02  1.91  1.93  1.94  
n-3LC-UFAe 23.33  23.10  22.94  22.86  22.17  
ARA/EPAf 0.30  0.31  0.42  0.45  0.51  
DHA/EPAg 0.82  1.28  1.67  2.01  2.33  
a SFA: saturated fatty acids. 
b MUFA: mono-unsaturated fatty acids. 
c n-6 PUFA: n-6 polyunsaturated fatty acids. 
d n-3 PUFA: n-3 polyunsaturated fatty acids. 
e n-3 LC-UFA: n-3 long chain polyunsaturated fatty acids. 
f ARA/EPA: 20:4n-6/20:5n-3. 
gDHA/EPA: 22:6n-3/20:5n-3. 
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Table 6. Functional characterisation of the grouper Elovl4 elongase: Role in biosynthesis of very 
long-chain saturated fatty acids (FA). Results are expressed as an area percentage of total saturated 
FA C24 found in yeast transformed with either the empty pYES2 vector (Control) or the grouper 
elovl4 ORF. Results are means ± standard deviations (N=3). Asterisks (“*”) indicate means are 
statistically different between treatments (Student’s t-test, P<0.05). 
 
       
 FA  Control  Elovl4  
       
 24:0  9.1±0.4  6.9±1.2  
 26:0  81.5±3.1  69.5±2.5 *  
 28:0  7.5±2.8  20.9±0.5 *  
 30:0  1.5±0.1  2.4±0.8  
 32:0  0.3±0.2  0.4±0.2  
 34:0  nd  0.0±0.1  
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
Table 7. Functional characterisation of the grouper Elovl4 elongase: conversions of 
polyunsaturated fatty acid (FA) substrates. Conversions were calculated for each 
stepwise elongation according to the formula [areas of first product and longer chain 
products / (areas of all products with longer chain than substrate + substrate area)] 
×100. The substrate FA varies as indicated in each step-wise elongation. 
 
  
  
  
  
 
 FA substrate  FA Product  % Conversion  Elongation  
 
     
  
 
 18:4n-3  20:4n-3  5.6  C1834  
   22:4n-3  40.0  C2034  
   24:4n-3  80.8  C2234  
   26:4n-3  96.1  C2434  
   28:4n-3  97.8  C2634  
   30:4n-3  96.2  C2834  
   32:4n-3  80.6  C3034  
   34:4n-3  6.4  C3234  
         
 18:3n-6  20:3n-6  9.6  C1834  
   22:3n-6  52.4  C2034  
   24:3n-6  79.6  C2234  
   26:3n-6  95.0  C2434  
   28:3n-6  97.0  C2634  
   30:3n-6  94.4  C2834  
   32:3n-6  32.9  C3034  
   34:3n-6  2.4  C3234  
         
 20:5n-3  22:5n-3  29.9  C2036  
   24:5n-3  72.0  C2236  
   26:5n-3  86.4  C2436  
   28:5n-3  97.3  C2636  
   30:5n-3  99.2  C2836  
   32:5n-3  89.5  C3036  
   34:5n-3  25.5  C3236  
 
  36:5n-3  0.9 
 
C3436  
 
     
  
 
 20:4n-6  22:4n-6  33.1  C2036  
   24:4n-6  66.2  C2236  
   26:4n-6  80.9  C2436  
   28:4n-6  92.3  C2636  
   30:4n-6  95.0  C2836  
   32:4n-6  53.5  C3036  
   34:4n-6  5.4  C3236  
 
  36:4n-6  1.4 
 
C3436  
 
     
  
 
 22:5n-3  24:5n-3  43.8  C2236  
   26:5n-3  81.8  C2436  
   28:5n-3  96.1  C2636  
   30:5n-3  99.0  C2836  
   32:5n-3  85.4  C3036  
   34:5n-3  16.4  C3236  
37 
 
 
  36:5n-3  0.7 
 
C3436  
 
     
  
 
 22:4n-6  24:4n-6  51.0  C2236  
   26:4n-6  86.0  C2436  
   28:4n-6  95.6  C2636  
   30:4n-6  97.5  C2836  
   32:4n-6  61.0  C3036  
   34:4n-6  7.7  C3236  
   36:4n-6  1.2  C3436  
         
 22:6n-3  24:6n-3  8.8  C2234  
   26:6n-3  100.0  C2434  
   28:6n-3  100.0  C2634  
   30:6n-3  75.4  C2834  
   32:6n-3  89.1  C3034  
   34:6n-3  10.8  C3234  
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
